ArticleRadiological physics and technology2026
Effects of medium thickness on cellular energy deposition in boron neutron capture therapy.
Article in Radiological physics and technology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Boron Neutron Capture Therapy is dependent on localized energy deposition of alpha particles and lithium nuclei. However, deviations and inconsistencies in cellular responses to neutron beams are frequently reported in radiobiological studies. This technical note investigates dosimetric impact of the overlying medium thickness on a [Formula: see text] cellular array using Monte Carlo method. [Formula: see text]B concentrations ranging from 0 to 80 ppm were evaluated to explicitly quantify energy partitioning between the cytoplasm and nucleus. Our findings demonstrate that minor variations in the aqueous medium layer severely attenuate the thermal neutron flux, leading to a marked decrease in the absolute dose deposited in the cellular targets. Specifically, increasing the medium thickness from 100 μm to 800 μm resulted in a [Formula: see text] reduction in the total cellular dose at 80 ppm. These results highlight the critical necessity of controlling and reporting fluid levels in BNCT in vitro experiments to prevent dosimetric variations and ensure reproducible biological outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.